Which of the following courses of action is the most appropriate if an auditor concludes that there is a high risk of material misstatement?

Determine whether the risk of material misstatement would increase, decrease, or not change for each of the following independent issues. Each choice may be used once, more than once, or not at all. Assume each issue is material to the auditor.

What type of agent is hypertonic saline considered in respiratory therapy?

What should be monitored to evaluate the effectiveness of adrenergic bronchodilator therapy in patients with respiratory conditions?

What does the pharmacokinetic phase of drug action describe?

What indicates appropriate therapeutic response when using LABA medications?

What is the primary indication for using Dornase alfa (Pulmozyme) in patients with cystic fibrosis (CF)?

Which of the following is a short-acting β2 agonist (SABA) commonly used as a rescue agent?

What is the mechanism of action of anticholinergic bronchodilators?

What type of drug would you classify as an adrenergic agent?